Know Cancer

or
forgot password

Newer Breast MRI Sequences for the Evaluation of Breast Cancer -FIESTA, Vibrant-DE and IDEAL: Feasibility Evaluation


N/A
21 Years
N/A
Open (Enrolling)
Female
Breast Cancer

Thank you

Trial Information

Newer Breast MRI Sequences for the Evaluation of Breast Cancer -FIESTA, Vibrant-DE and IDEAL: Feasibility Evaluation


Inclusion Criteria:



- Female patients over the age of 21 undergoing a diagnostic Breast MRI.

Exclusion Criteria:

- Patients who would be normally excluded from undergoing an MRI examination

- Patients with a pacemaker, aneurysm clip or any other condition that would warrant
avoidance of a strong magnetic field.

- Patients under the age of 21.

- Female patients who are pregnant.

Type of Study:

Interventional

Study Design:

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

To evaluate the feasibility of three new pulse sequences for breast MRI using newly developed software; FIESTA, Vibrant DE and IDEAL

Outcome Time Frame:

conclusion of the study

Safety Issue:

No

Principal Investigator

Elizabeth Morris, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

07-091

NCT ID:

NCT00579800

Start Date:

July 2007

Completion Date:

December 2013

Related Keywords:

  • Breast Cancer
  • Vibrant-DE
  • IDEAL
  • MRI
  • Breast
  • 07-091
  • Breast Neoplasms

Name

Location

Memorial Sloan-Kettering Cancer CenterNew York, New York  10021